Bipolar Disorder: Clinical Trials

51 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed. 51 Phase 1, 13 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 151Completed 51
Phase 213Completed 13

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 51 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
Group A. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by anxiety disorders and depression., Group B. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by PTSD, Group C. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder. - Anxiety, Depression
Phase 1CompletedRakitzi, Stavroula1072025-06-022026-08-04
A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode
SEP-380135, Placebo - Schizophrenia, Major Depressive Disorder (MDD)
Phase 1CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.432024-11-072026-04-24
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
ABBV-932, Placebo for ABBV-932 - Healthy Volunteers, Generalized Anxiety Disorder (GAD)
Phase 1CompletedAbbVie722023-08-312025-03-17
Pentoxifylline for Treatment of Resistant Major Depression
Pentoxifylline, Placebo - Resistant Major Depression
Phase 1 / Phase 2CompletedHawler Medical University602021-12-152022-09-07
Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3
Mobile intervention - Bipolar Disorder, Psychosocial Intervention
Phase 1CompletedUniversity of Wisconsin, Madison302019-09-132022-01-03
Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
Seroquel IR 300mg, Seroquel IR 25mg, Quetiapine Formulation A 300mg - Bipolar Disorder, Schizophrenia
Phase 1CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.582019-03-272020-09-02
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
Ketamine, Perampanel, Placebo - Depressive Disorder, Major, Post Traumatic Stress Disorder
Phase 1CompletedYale University132018-11-292025-02-07
Technology Enhanced Family Treatment
Family-Focused Treatment with MCC App - Mood Disorders, Bipolar Disorder
Phase 1 / Phase 2CompletedUniversity of California, Los Angeles652018-11-152024-05-28
Ketamine as an Adjunctive Therapy for Major Depression
Ketamine, Midazolam - Major Depressive Episode, Unipolar Depression
Phase 1CompletedSt Patrick's Hospital, Ireland252017-09-072020-01-18
Differential Responses to Drugs and Sweet Tastes
Placebo oral capsule, d-amphetamine 10 mg oral capsule, d-amphetamine 20 mg oral capsule - Bipolar II Disorder
Phase 1CompletedUniversity of Chicago932017-02-092023-02-22
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
Lamotrigine - Bipolar Disorder
Phase 1CompletedGlaxoSmithKline162015-09-062017-05-08
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
IP6, Lamotrigine - Bipolar Disorder, Manic Depression
Phase 1CompletedSan Diego Veterans Healthcare System82014-05-012018-08-01
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Aripiprazole, oral formulation, Olanzapine, oral formulation, Paliperidone, oral formulation - Psychotic Disorders, Schizophrenia
Phase 1CompletedJanssen Research & Development, LLC3052014-02-012015-10-29
Ketamine for Suicidality in Bipolar Depression
Ketamine, Midazolam - Bipolar Disorder, Major Depressive Episode
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute162013-09-012020-03-11
Bio-equivalence Study Between SAPHRIS and Asenapine
SAPHRIS, Asenapine - Schizophrenia, Bipolar Disorder
Phase 1CompletedSun Pharmaceutical Industries Limited652013-07-012021-04-30
Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders
Mindfulness-based cognitive therapy - Major Depressive Disorder, Bipolar Disorder
Phase 1CompletedUniversity of California, Los Angeles392012-10-012014-05-30
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
MagVenture MagPro MST, RUL ECT - Depression, Major Depressive Episode
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute182012-08-012020-09-03
Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
Nutrition, Exercise, and Wellness (NEW) psychotherapy, Typically consists of at least one FDA-approved mood stabilizer - Bipolar Disorder
Phase 1 / Phase 2CompletedMassachusetts General Hospital382012-05-212018-06-07
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
iloperidone (oral tablet) - Safety and Tolerability of Iloperidone
Phase 1CompletedVanda Pharmaceuticals332011-10-012016-06-13
Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
Transcranial direct current stimulation (Eldith DC Stimulator) - Bipolar Disorder
Phase 1CompletedThe University of New South Wales152011-09-012015-11-03

Showing 20 of 51. Sign in to see all of them.

Narrower conditions

Schizophrenia (11)  ·  Depression (8)  ·  Depressive Disorder, Major (7)  ·  Psychotic Disorders (5)  ·  Alcoholism (3)  ·  Depressive Disorder (3)  ·  Epilepsy (3)  ·  Anxiety Disorders (2)  ·  Mood Disorders (2)  ·  Seizures (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Substance-Related Disorders (2)  ·  Behavior, Addictive (1)  ·  Cocaine-Related Disorders (1)

Broader conditions

Bipolar and Related Disorders (51)  ·  Mental Disorders (51)  ·  Mood Disorders (49)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (12)  ·  Behavior (11)  ·  Behavioral Symptoms (8)  ·  Depressive Disorder (6)  ·  Nervous System Diseases (6)  ·  Chemically-Induced Disorders (5)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Alcohol-Related Disorders (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Valproic Acid (4)  ·  Ketamine (3)  ·  Lamotrigine (3)  ·  2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (2)  ·  Aripiprazole (2)  ·  Lithium (2)  ·  Midazolam (2)  ·  Paliperidone Palmitate (2)  ·  Risperidone (2)  ·  Topiramate (2)  ·  vixotrigine (2)  ·  3-(6-p-tolylpyridin-3-yloxy)-1-azabicyclo(2.2.2)octane (1)  ·  Acamprosate (1)  ·  Bupropion (1)  ·  Carbamazepine (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4)  ·  New York State Psychiatric Institute (3)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (3)  ·  University of California, Los Angeles (3)  ·  University of Miami (3)  ·  Biogen (2)  ·  Eli Lilly and Company (2)  ·  GlaxoSmithKline (2)  ·  Massachusetts General Hospital (2)  ·  Pfizer (2)  ·  Sandoz (2)  ·  Yale University (2)  ·  AbbVie (1)  ·  AstraZeneca (1)  ·  Dartmouth-Hitchcock Medical Center (1)

Countries

United States (34)  ·  Singapore (3)  ·  United Kingdom (3)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  China (1)  ·  Germany (1)  ·  Greece (1)  ·  Iraq (1)  ·  Ireland (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Ihsan M Salloum, MD, MPH (2)  ·  Armen Arevian, MD (1)  ·  Aude Henin, Ph.D. (1)  ·  Barry F Chaitin, M.D. (1)  ·  Bryan K. Tolliver, M.D., Ph.D. (1)  ·  David A. Axelson, MD (1)

Results publications

PMID 18762591, PMID 19454920, PMID 20854181, PMID 26187603, PMID 26682997, PMID 27371157, PMID 28379964, PMID 29063592, PMID 29578646, PMID 32965227, PMID 33360365, PMID 34131914, PMID 35036831, PMID 37079363, PMID 38094620, PMID 39428602, PMID 40109484, PMID 40494497

NIH funding

2016 (1), K01MH112876 (1), K24DA000435 (1), R01AA015385 (1), R01DA019992 (1), R01MH059710 (1), R21MH062555 (1), R34MH081335 (1), R34MH083894 (1), R34MH090148 (1), R34MH117200 (1)